Saroja Pharma Industries India Limited (NSE:SAROJA)
India
· Delayed Price · Currency is INR 41.90
+0.90 (2.20%)
At close: May 26, 2025
NSE:SAROJA Revenue
Saroja Pharma Industries India had revenue of 187.24M INR in the half year ending September 30, 2024, a decrease of -29.45%. This brings the company's revenue in the last twelve months to 382.75M, down -14.51% year-over-year. In the fiscal year ending March 31, 2024, Saroja Pharma Industries India had annual revenue of 406.69M, down -18.97%.
Revenue (ttm)
382.75M
Revenue Growth
-14.51%
P/S Ratio
0.44
Revenue / Employee
23.92M
Employees
16
Market Cap
168.46M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2024 | 406.69M | -95.24M | -18.97% |
| Mar 31, 2023 | 501.93M | -54.39M | -9.78% |
| Mar 31, 2022 | 556.33M | 189.71M | 51.75% |
| Mar 31, 2021 | 366.62M | 195.82M | 114.65% |
| Mar 31, 2020 | 170.80M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Reliance Industries | 9,646.93B |
| HDFC Bank | 2,728.47B |
| Tata Consultancy Services | 2,553.24B |
| Bharti Airtel | 1,729.85B |
| ICICI Bank | 2,006.54B |
| State Bank of India | 3,429.39B |
| Infosys | 1,647.16B |
| Bajaj Finance | 369.88B |